TY Howton
Chief Operating Officer bij SOLID BIOSCIENCES INC.
Vermogen: 102 351 $ op 31-03-2024
Profiel
David Tyronne Howton is currently the Chief Operating Officer at Solid Biosciences, Inc. He previously held positions as Director at Make-A-Wish Foundation of Massachusetts, Chief Healthcare Compliance Officer at Genentech, Inc., Secretary, Chief Legal Officer & Senior VP at Vertex Pharmaceuticals, Inc., Secretary, Senior Vice President & General Counsel at Sarepta Therapeutics, Inc., and Chief Operating Officer & General Counsel at Aavantibio, Inc. He obtained his undergraduate degree from Yale University and his graduate degree from Northwestern University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SOLID BIOSCIENCES INC.
0.02% | 13-02-2024 | 7 684 ( 0.02% ) | 102 351 $ | 31-03-2024 |
Actieve functies van TY Howton
| Bedrijven | Functie | Begin |
|---|---|---|
| SOLID BIOSCIENCES INC. | Chief Operating Officer | 01-09-2023 |
Eerdere bekende functies van TY Howton
| Bedrijven | Functie | Einde |
|---|---|---|
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Chief Operating Officer | 01-12-2022 |
| SAREPTA THERAPEUTICS, INC. | General Counsel | - |
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 12-06-2012 |
| Make-A-Wish Foundation of Massachusetts | Director/Board Member | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Opleiding van TY Howton
| Yale University | Undergraduate Degree |
| Northwestern University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| SOLID BIOSCIENCES INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Make-A-Wish Foundation of Massachusetts | |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Health Technology |
